When those shRNAs were tested in vivo, they showed a dramatic effect on tumor induction (8% and 42%; Fig 3F and Table 1C), which supports a critical role of the MAPK pathway leading to the stimulation of c-Fos in tumorigenesis. This evidence concerns the gene FOS and neoplasm.